Target Price | $148.00 |
Price | $4.32 |
Potential |
3,325.93%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Sonnet BioTherapeutics Holdings Inc 2025 .
The average Sonnet BioTherapeutics Holdings Inc target price is $148.00.
This is
3,325.93%
register free of charge
$240.00
5,455.56%
register free of charge
$56.00
1,196.30%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Sonnet BioTherapeutics Holdings Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sonnet BioTherapeutics Holdings Inc stock has an average upside potential 2025 of
3,325.93%
register free of charge
|
Sep '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 0.15 | 0.05 |
57.14% | 66.67% | |
Net Margin | -62,885.33% | -34,944.00% |
125.17% | 44.43% |
2 Analysts have issued a sales forecast Sonnet BioTherapeutics Holdings Inc 2024 . The average Sonnet BioTherapeutics Holdings Inc sales estimate is
This results in the following potential growth metrics:
The average Sonnet BioTherapeutics Holdings Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2023 | -62,885.33% | 125.17% |
---|---|---|
2024 |
-34,944.00%
44.43%
Unlock
|
Sep '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -145.12 | -26.88 |
3.50% | 81.48% | |
P/E | negative | |
EV/Sales | negative |
Based on analysts' sales estimates for 2024, the Sonnet BioTherapeutics Holdings Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current | -7.50 | 73.39% |
---|---|---|
2024 |
-9.00
20.00%
Unlock
|
Current | 49.17 | 315.84% |
---|---|---|
2024 |
59.00
20.00%
Unlock
|
Sonnet BioTherapeutics Holdings Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.